Palisade Bio (PALI) Non-cash Items (2015 - 2026)
Palisade Bio (PALI) reported Non-cash Items of $100000.0 for Q1 2026, down 66.67% year-over-year from $300000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q4 2025.
Palisade Bio (PALI) Non-cash Items (2015 - 2026) Analysis & Trends
Palisade Bio (PALI) has 12 years of Non-cash Items data on file, last reported at $100000.0 in Q1 2026.
- Non-cash Items for Q1 2026 came in at $100000.0, down 66.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $100000.0 (down 66.67% YoY), and the FY2025 annual result was $100000.0, down 50.0% from the prior year.
- Non-cash Items held at $100000.0 in Q1 2026 per PALI's latest filing, from $100000.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $1.1 million in Q3 2022 and troughed at $22383.0 in Q1 2023.
- A 5-year average of $292735.1 and a median of $200000.0 in 2024 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2022 and 2024: Non-cash Items plunged 97.64% in 2022, then jumped 1687.07% in 2024.
- A 5-year view of Non-cash Items shows it stood at $1.1 million in 2022, then plunged by 36.36% to $700000.0 in 2023, then plunged by 71.43% to $200000.0 in 2024, then sank by 50.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- Business Quant data shows PALI's Non-cash Items at $100000.0 in Q1 2026, $100000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Palisade Bio | 357.48 Mn | 227.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |